394 related articles for article (PubMed ID: 35570845)
21. Next generation human skin constructs as advanced tools for drug development.
Abaci HE; Guo Z; Doucet Y; Jacków J; Christiano A
Exp Biol Med (Maywood); 2017 Nov; 242(17):1657-1668. PubMed ID: 28592171
[TBL] [Abstract][Full Text] [Related]
22. Human organotypic bioconstructs from organ-on-chip devices for human-predictive biological insights on drug candidates.
Cavero I; Guillon JM; Holzgrefe HH
Expert Opin Drug Saf; 2019 Aug; 18(8):651-677. PubMed ID: 31268355
[TBL] [Abstract][Full Text] [Related]
23. Human Organs-on-Chips: A Review of the State-of-the-Art, Current Prospects, and Future Challenges.
Zarrintaj P; Saeb MR; Stadler FJ; Yazdi MK; Nezhad MN; Mohebbi S; Seidi F; Ganjali MR; Mozafari M
Adv Biol (Weinh); 2022 Jan; 6(1):e2000526. PubMed ID: 34837667
[TBL] [Abstract][Full Text] [Related]
24. Advanced In Vitro Lung Models for Drug and Toxicity Screening: The Promising Role of Induced Pluripotent Stem Cells.
Moreira A; Müller M; Costa PF; Kohl Y
Adv Biol (Weinh); 2022 Feb; 6(2):e2101139. PubMed ID: 34962104
[TBL] [Abstract][Full Text] [Related]
25. Organ-on-a-chip meets artificial intelligence in drug evaluation.
Deng S; Li C; Cao J; Cui Z; Du J; Fu Z; Yang H; Chen P
Theranostics; 2023; 13(13):4526-4558. PubMed ID: 37649608
[TBL] [Abstract][Full Text] [Related]
26. A Personalized Glomerulus Chip Engineered from Stem Cell-Derived Epithelium and Vascular Endothelium.
Roye Y; Bhattacharya R; Mou X; Zhou Y; Burt MA; Musah S
Micromachines (Basel); 2021 Aug; 12(8):. PubMed ID: 34442589
[TBL] [Abstract][Full Text] [Related]
27. Organ-On-A-Chip Platforms: A Convergence of Advanced Materials, Cells, and Microscale Technologies.
Ahadian S; Civitarese R; Bannerman D; Mohammadi MH; Lu R; Wang E; Davenport-Huyer L; Lai B; Zhang B; Zhao Y; Mandla S; Korolj A; Radisic M
Adv Healthc Mater; 2018 Jan; 7(2):. PubMed ID: 29034591
[TBL] [Abstract][Full Text] [Related]
28. Academic User View: Organ-on-a-Chip Technology.
Busek M; Aizenshtadt A; Amirola-Martinez M; Delon L; Krauss S
Biosensors (Basel); 2022 Feb; 12(2):. PubMed ID: 35200386
[TBL] [Abstract][Full Text] [Related]
29. Organ-On-A-Chip: A Survey of Technical Results and Problems.
Danku AE; Dulf EH; Braicu C; Jurj A; Berindan-Neagoe I
Front Bioeng Biotechnol; 2022; 10():840674. PubMed ID: 35223800
[TBL] [Abstract][Full Text] [Related]
30. iPSCs in Neurodegenerative Disorders: A Unique Platform for Clinical Research and Personalized Medicine.
Pandey S; Jirásko M; Lochman J; Chvátal A; Chottova Dvorakova M; Kučera R
J Pers Med; 2022 Sep; 12(9):. PubMed ID: 36143270
[TBL] [Abstract][Full Text] [Related]
31. Towards Multi-Organoid Systems for Drug Screening Applications.
Miranda CC; Fernandes TG; Diogo MM; Cabral JMS
Bioengineering (Basel); 2018 Jun; 5(3):. PubMed ID: 29933623
[TBL] [Abstract][Full Text] [Related]
32. The application of organ-on-chip models for the prediction of human pharmacokinetic profiles during drug development.
Keuper-Navis M; Walles M; Poller B; Myszczyszyn A; van der Made TK; Donkers J; Eslami Amirabadi H; Wilmer MJ; Aan S; Spee B; Masereeuw R; van de Steeg E
Pharmacol Res; 2023 Sep; 195():106853. PubMed ID: 37473876
[TBL] [Abstract][Full Text] [Related]
33. Controlling Differentiation of Stem Cells for Developing Personalized Organ-on-Chip Platforms.
Geraili A; Jafari P; Hassani MS; Araghi BH; Mohammadi MH; Ghafari AM; Tamrin SH; Modarres HP; Kolahchi AR; Ahadian S; Sanati-Nezhad A
Adv Healthc Mater; 2018 Jan; 7(2):. PubMed ID: 28910516
[TBL] [Abstract][Full Text] [Related]
34. Induced Pluripotent Stem Cell (iPSC)-Based Neurodegenerative Disease Models for Phenotype Recapitulation and Drug Screening.
Chang CY; Ting HC; Liu CA; Su HL; Chiou TW; Lin SZ; Harn HJ; Ho TJ
Molecules; 2020 Apr; 25(8):. PubMed ID: 32344649
[TBL] [Abstract][Full Text] [Related]
35. Liver organ-on-chip models for toxicity studies and risk assessment.
Messelmani T; Morisseau L; Sakai Y; Legallais C; Le Goff A; Leclerc E; Jellali R
Lab Chip; 2022 Jun; 22(13):2423-2450. PubMed ID: 35694831
[TBL] [Abstract][Full Text] [Related]
36. Recent Updates on Induced Pluripotent Stem Cells in Hematological Disorders.
Wattanapanitch M
Stem Cells Int; 2019; 2019():5171032. PubMed ID: 31191673
[TBL] [Abstract][Full Text] [Related]
37. Induced Pluripotent Stem Cells (iPSCs)-Roles in Regenerative Therapies, Disease Modelling and Drug Screening.
Aboul-Soud MAM; Alzahrani AJ; Mahmoud A
Cells; 2021 Sep; 10(9):. PubMed ID: 34571968
[TBL] [Abstract][Full Text] [Related]
38. Induced pluripotent stem cells (iPSCs) as game-changing tools in the treatment of neurodegenerative disease: Mirage or reality?
Yousefi N; Abdollahii S; Kouhbanani MAJ; Hassanzadeh A
J Cell Physiol; 2020 Dec; 235(12):9166-9184. PubMed ID: 32437029
[TBL] [Abstract][Full Text] [Related]
39. Concise review: modeling central nervous system diseases using induced pluripotent stem cells.
Zeng X; Hunsberger JG; Simeonov A; Malik N; Pei Y; Rao M
Stem Cells Transl Med; 2014 Dec; 3(12):1418-28. PubMed ID: 25368377
[TBL] [Abstract][Full Text] [Related]
40. Application of induced pluripotent stem cell technology for the investigation of hematological disorders.
Dolatshad H; Tatwavedi D; Ahmed D; Tegethoff JF; Boultwood J; Pellagatti A
Adv Biol Regul; 2019 Jan; 71():19-33. PubMed ID: 30341008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
